FMT
YMAB

First Mercantile Trust’s Y-mAbs Therapeutics YMAB Stock Holding History

First Mercantile Trust’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$67K Sell
2,350
-95
-4% -$2.99K 0.01% 741
2021
Q2 		$83K Sell
2,445
-304
-11% -$9.76K 0.01% 736
2021
Q1 		$83K Buy
2,749
+274
+11% +$11.2K 0.01% 721
2020
Q4 		$123K Sell
2,475
-72
-3% -$3.33K 0.01% 623
2020
Q3 		$122K Sell
2,547
-101
-4% -$4.02K 0.01% 610
2020
Q2 		$114K Buy
+2,648
New +$100K 0.01% 615

Other funds holding YMAB

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

First Mercantile Trust's YMAB Position: Q3 2021 in Review

First Mercantile Trust reduced its Y-mAbs Therapeutics (YMAB) stake by 3.9% in Q3 2021, selling an estimated $2.99K and leaving 2,350 shares worth $67K. The position accounts for 0.01% of the portfolio, ranked #741.

First Mercantile Trust first reported a position in YMAB in Q2 2020 and has held it in 6 quarters since. The position peaked at $123K in Q4 2020. 97 funds tracked by Wall St. Rank hold YMAB as of Q3 2021.

  • First Mercantile Trust held 2,350 shares of Y-mAbs Therapeutics worth $67K as of Q3 2021.
  • First Mercantile Trust sold 95 Y-mAbs Therapeutics shares in Q3 2021, an estimated $2.99K.
  • Y-mAbs Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #741 holding.
  • First Mercantile Trust first reported a position in Y-mAbs Therapeutics in Q2 2020 and has held it in 6 quarters since.
  • First Mercantile Trust's Y-mAbs Therapeutics position peaked at $123K in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.